Wang D et al. |
Accelerated calvarial healing in mice lacking Toll-like receptor 4. |
2012 |
PLoS ONE |
pmid:23071670
|
D'Abramo A et al. |
Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. |
2016 |
PLoS ONE |
pmid:26913505
|
Bumdelger B et al. |
Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. |
2016 |
PLoS ONE |
pmid:26783750
|
Totoson P et al. |
Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. |
2016 |
PLoS ONE |
pmid:26761790
|
Plasilova M et al. |
Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). |
2011 |
PLoS ONE |
pmid:21738662
|
Liu W et al. |
Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. |
2015 |
PLoS ONE |
pmid:26571489
|
Weiss RM et al. |
Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. |
2013 |
PLoS ONE |
pmid:23762316
|
Roato I et al. |
Osteoclasts are active in bone forming metastases of prostate cancer patients. |
2008 |
PLoS ONE |
pmid:18978943
|
Tao H et al. |
P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. |
2011 |
PLoS ONE |
pmid:21886782
|
Steensma MR et al. |
Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. |
2013 |
PLoS ONE |
pmid:23922683
|
Yang DC et al. |
cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. |
2008 |
PLoS ONE |
pmid:18253488
|
Grosjean F et al. |
Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. |
2015 |
PLoS ONE |
pmid:26247358
|
Lewis JR et al. |
Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. |
2015 |
PLoS ONE |
pmid:26222774
|
Wang J et al. |
RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. |
2015 |
PLoS ONE |
pmid:26218592
|
Loiselle AE et al. |
Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. |
2013 |
PLoS ONE |
pmid:24260576
|
Lin C et al. |
The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. |
2013 |
PLoS ONE |
pmid:23469146
|
Benito-Martin A et al. |
Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. |
2013 |
PLoS ONE |
pmid:24058411
|
Morena M et al. |
Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. |
2012 |
PLoS ONE |
pmid:22567137
|
Goyden J et al. |
The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. |
2015 |
PLoS ONE |
pmid:26030441
|
Ehlken C et al. |
Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. |
2015 |
PLoS ONE |
pmid:25978399
|
de Araújo Júnior RF et al. |
Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. |
2013 |
PLoS ONE |
pmid:23843954
|
Bortolin RH et al. |
Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. |
2015 |
PLoS ONE |
pmid:25933189
|
Jiang W et al. |
Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. |
2013 |
PLoS ONE |
pmid:24116163
|
Kim KR et al. |
15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. |
2015 |
PLoS ONE |
pmid:25859665
|
Lanza D et al. |
Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. |
2015 |
PLoS ONE |
pmid:25635832
|
Marano RJ et al. |
Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. |
2013 |
PLoS ONE |
pmid:23667691
|
Kam WW et al. |
The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. |
2012 |
PLoS ONE |
pmid:22295097
|
Mabilleau G and Sabokbar A |
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. |
2009 |
PLoS ONE |
pmid:19137064
|
Holt V et al. |
Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. |
2014 |
PLoS ONE |
pmid:25302610
|
Schündeln MM et al. |
Impairment of bone health in pediatric patients with hemolytic anemia. |
2014 |
PLoS ONE |
pmid:25299063
|
Davaine JM et al. |
Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. |
2014 |
PLoS ONE |
pmid:25259713
|
Saito K et al. |
Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. |
2013 |
PLoS ONE |
pmid:23349978
|
Giuliani AL et al. |
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. |
2014 |
PLoS ONE |
pmid:25226385
|
Kebschull M et al. |
Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. |
2013 |
PLoS ONE |
pmid:23355901
|
Buckle CH et al. |
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. |
2012 |
PLoS ONE |
pmid:22952578
|
Shen P et al. |
Expression of osteoprotegerin in placenta and its association with preeclampsia. |
2012 |
PLoS ONE |
pmid:22952959
|
Chen YH et al. |
Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. |
2012 |
PLoS ONE |
pmid:22957004
|
Ozaki Y et al. |
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. |
2017 |
PLoS ONE |
pmid:28937990
|
Tschiderer L et al. |
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. |
2017 |
PLoS ONE |
pmid:28837646
|
Tyagi AM et al. |
Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. |
2012 |
PLoS ONE |
pmid:22970248
|
Shu R et al. |
Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. |
2017 |
PLoS ONE |
pmid:28081119
|
Araújo AA et al. |
Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. |
2014 |
PLoS ONE |
pmid:24819928
|
Xue Y et al. |
Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. |
2012 |
PLoS ONE |
pmid:23144698
|
Gómez-Vaquero C et al. |
Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. |
2016 |
PLoS ONE |
pmid:27911913
|
Kim CS et al. |
Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. |
2016 |
PLoS ONE |
pmid:27855207
|
Zanotti S et al. |
Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. |
2014 |
PLoS ONE |
pmid:24489784
|
Røysland R et al. |
Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. |
2016 |
PLoS ONE |
pmid:27463973
|
Caetano-Lopes J et al. |
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. |
2011 |
PLoS ONE |
pmid:21347301
|
Tawfeek H et al. |
Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. |
2010 |
PLoS ONE |
pmid:20808842
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|
Kassem A et al. |
Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. |
2016 |
PLoS ONE |
pmid:27311019
|
Titanji K et al. |
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. |
2014 |
PLoS Pathog. |
pmid:25393853
|
Lis GJ et al. |
Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. |
2016 |
Pol. Arch. Med. Wewn. |
pmid:27003233
|
Janda K et al. |
Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. |
2013 |
Pol. Arch. Med. Wewn. |
pmid:23535831
|
Nehring P et al. |
Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. |
2013 |
Pol. Arch. Med. Wewn. |
pmid:23299915
|
Jasiewicz M et al. |
Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. |
2014 |
Pol. Arch. Med. Wewn. |
pmid:25188298
|
Stajszczyk M |
[Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism]. |
2002 |
Pol. Arch. Med. Wewn. |
pmid:12600190
|
Adamczyk T et al. |
Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. |
2012 |
Pol. Arch. Med. Wewn. |
pmid:22237719
|
Ambroszkiewicz J et al. |
[Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria]. |
2008 |
Pol. Merkur. Lekarski |
pmid:18839616
|
Kmieć Z and Sokołowska I |
[Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities]. |
2007 |
Pol. Merkur. Lekarski |
pmid:17684931
|
Hen K et al. |
[Osteoprotegerin--a new atherosclerosis marker]. |
2011 |
Pol. Merkur. Lekarski |
pmid:22097184
|
Ostrowska Z et al. |
Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. |
2011 |
Postepy Hig Med Dosw (Online) |
pmid:22100799
|
Ostrowska Z |
[Menopause, obesity, and bone status]. |
2009 |
Postepy Hig Med Dosw (Online) |
pmid:19252463
|
Ostrowska Z et al. |
Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. |
2013 |
Postepy Hig Med Dosw (Online) |
pmid:23752595
|
Zdzisińska B and Kandefer-Szerszeń M |
[The role of RANK/RANKL and OPG in multiple myeloma]. |
2006 |
Postepy Hig Med Dosw (Online) |
pmid:17013366
|
Majerczyk M et al. |
[Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. |
2015 |
Postepy Hig Med Dosw (Online) |
pmid:27259222
|
Stanisławowski M and Kmieć Z |
[The participation of RANK, RANKL and OPG in tumor osteolysis]. |
2009 |
Postepy Hig Med Dosw (Online) |
pmid:19502684
|
Ostrowska Z et al. |
 Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. |
2012 |
Postepy Hig Med Dosw (Online) |
pmid:23001207
|
Wang Y et al. |
Chicken receptor activator of nuclear factor-kappaB ligand induces formation of chicken osteoclasts from bone marrow cells and also directly activates mature osteoclasts. |
2008 |
Poult. Sci. |
pmid:18931186
|
Jiang S et al. |
Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. |
2013 |
Poult. Sci. |
pmid:23687138
|
Fu YX et al. |
Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. |
2013 |
Poult. Sci. |
pmid:23687158
|
Ta HM et al. |
Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21059944
|
Yasuda H et al. |
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9520411
|
Hsu H et al. |
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10097072
|
Shimamura M et al. |
OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24847069
|
Xiong L et al. |
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. |
2015 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25733894
|
Duheron V et al. |
Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21402940
|
Chen W et al. |
Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24733914
|
Wei W et al. |
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. |
2012 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22315431
|
Krause U et al. |
Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20150512
|
Pearse RN et al. |
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11562486
|
Raffai RL et al. |
Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11553788
|
Toraldo G et al. |
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12490655
|
Li JY et al. |
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21187391
|
Baud'huin M et al. |
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. |
2012 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22761317
|
Cozzani M et al. |
Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption. |
2005 |
Prog Orthod |
pmid:16276433
|
Malik P et al. |
Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. |
2013 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:23380173
|
Kuroyanagi G et al. |
Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. |
2014 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:24813642
|
Fujita D et al. |
Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12711253
|
Poulsen RC et al. |
Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. |
2008 |
Prostaglandins Other Lipid Mediat. |
pmid:18077200
|
Li X et al. |
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. |
2002 |
Prostaglandins Other Lipid Mediat. |
pmid:12013525
|
Kuroyanagi G et al. |
(-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. |
2017 |
Prostaglandins Other Lipid Mediat. |
pmid:28163121
|
Blackwell KA et al. |
Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. |
2009 |
Prostaglandins Other Lipid Mediat. |
pmid:19744575
|
Wiercinska-Drapalo A et al. |
Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients. |
2005 |
Prostaglandins Other Lipid Mediat. |
pmid:16303613
|
Yamamoto N et al. |
Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. |
|
Prostaglandins Other Lipid Mediat. |
pmid:25677506
|
Corey E et al. |
Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. |
2002 |
Prostate |
pmid:11992617
|
Burton DW et al. |
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP. |
2005 |
Prostate |
pmid:15389781
|
Yonou H et al. |
Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts. |
2007 |
Prostate |
pmid:17394194
|
Eaton CL et al. |
Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer. |
2004 |
Prostate |
pmid:15042606
|
Lin DL et al. |
Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro. |
2001 |
Prostate |
pmid:11351351
|